Site-Specific Responses of Joint and Entheses to Tofacitinib in Patients with Ankylosing Spondylitis: A Post Hoc Analysis of a Phase 3 Trial

被引：0
|
作者：
Micheroli, Raphael [1 ]
Killeen, Tim [2 ]
Jo, Hyejin [3 ]
Kwok, Kenneth [3 ]
Elzorkany, Bassel [4 ]
Ospelt, Caroline [5 ]
Ciurea, Adrian [6 ]
Nissen, Michael [7 ]
机构：
[1] Univ Hosp Zurich, Dept Rheumatol, Zurich, Switzerland
[2] Pfizer Ltd, Tadworth, Switzerland
[3] Pfizer Inc, New York, NY USA
[4] Cairo Univ, Dept Rheumatol, Cairo, Egypt
[5] Univ Zurich, Univ Zurich Hosp, Dept Rheumatol, Ctr Expt Rheumatol, Zurich, Switzerland
[6] Univ Hosp Zurich, Zurich, Switzerland
[7] Hop Univ Geneve, Geneva, Switzerland
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0404
引用
收藏
页码：799 / 800
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety of Tofacitinib in Patients with Ankylosing Spondylitis by Baseline BMI: A Post Hoc Analysis of Phase 2 and Phase 3 Trials
    Norton, Hillary
    Sliwinska-Stanczyk, Paula
    Hala, Tomas
    Elzorkany, Bassel
    Stockert, Lori
    Shi, Harry
    Wang, Cunshan
    Paulissen, Jerome
    Ritchlin, Christopher
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 800 - 803
  • [2] Joint-specific Responses to Tofacitinib and Adalimumab in Patients with Psoriatic Arthritis: Post Hoc Analysis of a Phase 3 Study
    Ciurea, Adrian
    Killeen, Tim
    Micheroli, Raphael
    Gassman, Norina N.
    Jo, Hyejin
    Kwok, Kenneth
    Kudlacz, Elizabeth
    Distler, Oliver
    Ospelt, Caroline
    Frank-Bertoncelj, Mojca
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2811 - 2814
  • [3] Efficacy and Safety of Tofacitinib in Patients with Ankylosing Spondylitis by Prior bDMARD Treatment: Analysis of a Phase 3 Trial
    Deodhar, Atul
    Marzo-Ortega, Helena
    Wu, Joseph
    Wang, Cunshan
    Dina, Oluwaseyi
    Kanik, Keith S.
    Fallon, Lara
    Gensler, Lianne
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 840 - 843
  • [4] TOFACITINIB EFFICACY AND SAFETY IN PATIENTS WITH ANKYLOSING SPONDYLITIS BY BASELINE C-REACTIVE PROTEIN LEVELS: A POST HOC ANALYSIS
    Deodhar, A.
    Baraliakos, X.
    Magrey, M.
    Gensler, L. S.
    Thorat, A. V.
    Kinch, C.
    Pemmaraju, S.
    Cadatal, M. J.
    Nash, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1685 - 1686
  • [5] Tofacitinib Efficacy and Safety in Patients with Ankylosing Spondylitis by Baseline C-Reactive Protein Levels: A Post Hoc Analysis
    Deodhar, Atul
    Baraliakos, Xenofon
    Magrey, Marina Nighat
    Gensler, Lianne
    Thorat, Amit V.
    Pemmaraju, Surya
    Cadatal, Mary Jane
    Nash, Peter
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1012 - 1014
  • [6] Time to improvement of pain, morning stiffness, fatigue, and disease activity in patients with ankylosing spondylitis treated with tofacitinib: a post hoc analysis
    Navarro-Compan, Victoria
    Deodhar, Atul
    Bahiri, Rachid
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Rammaoui, Jihane
    [J]. ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)
  • [7] Tofacitinib Efficacy and Safety in Patients With Ankylosing Spondylitis by Prior Biologic Disease-Modifying Antirheumatic Drug Use: A Post Hoc Analysis
    Deodhar, Atul
    Marzo-Ortega, Helena
    Wu, Joseph
    Wang, Cunshan
    Dina, Oluwaseyi
    Kanik, Keith S.
    Fallon, Lara
    Gensler, Lianne S.
    [J]. ACR OPEN RHEUMATOLOGY, 2023, 5 (12) : 632 - 643
  • [8] EFFECT OF TOFACITINIB ON PATIENT-REPORTED OUTCOMES IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS FROM A PHASE 3 TRIAL
    Navarro-Compan, V.
    Wei, J. C. C.
    Van den Bosch, F.
    Magrey, M.
    Wang, L.
    Fleishaker, D.
    Cappelleri, J. C.
    Wang, C.
    Wu, J.
    Dina, O.
    Fallon, L.
    Strand, V.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 704 - 704
  • [9] Joint-specific Responses to Tofacitinib and Methotrexate in Rheumatoid Arthritis: A Post Hoc Analysis of Data from ORAL Start
    Frank-Bertoncelj, Mojca
    Distler, Oliver
    Killeen, Tim
    Kwok, Kenneth
    Wang, Lisy
    Ospelt, Caroline
    Ciurea, Adrian
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [10] Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis by Baseline C-Reactive Protein Level: Post Hoc Analysis of Phase II and Phase III Clinical Trials
    Deodhar, Atul
    Baraliakos, Xenofon
    Magrey, Marina
    Gensler, Lianne S.
    Thorat, Amit, V
    Pemmaraju, Surya Kiran
    Cadatal, Mary Jane
    Nash, Peter
    [J]. JOURNAL OF RHEUMATOLOGY, 2024, 51 (08) : 772 - 780
12345